148 related articles for article (PubMed ID: 25405848)
1. Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl‑2 pathway.
Qian C; Li P; Yan W; Shi L; Zhang J; Wang Y; Liu H; You Y
Mol Med Rep; 2015 Mar; 11(3):1951-5. PubMed ID: 25405848
[TBL] [Abstract][Full Text] [Related]
2. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
3. Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway.
Wang Q; Du J; Xu B; Xu L; Wang X; Liu J; Wang J
Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):501-8. PubMed ID: 27189511
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
Yan W; Qian C; Zhao P; Zhang J; Shi L; Qian J; Liu N; Fu Z; Kang C; Pu P; You Y
Neuro Oncol; 2010 Aug; 12(8):765-75. PubMed ID: 20511184
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.
Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K
Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells.
Cui Y; Yang F; He L
Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434
[TBL] [Abstract][Full Text] [Related]
8. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
[TBL] [Abstract][Full Text] [Related]
9. RLIP76 Depletion Enhances Autophagic Flux in U251 Cells.
Zhang C; Cai Z; Liang Q; Wang Q; Lu Y; Hu L; Hu G
Cell Mol Neurobiol; 2017 Apr; 37(3):555-562. PubMed ID: 27473470
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ILK promotes temozolomide resistance in glioma cells.
Liang F; Wang B; Bao L; Zhao YS; Zhang SM; Zhang SQ
Mol Med Rep; 2017 Mar; 15(3):1297-1304. PubMed ID: 28138714
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K
Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status.
Chen L; Zhang J; Han L; Zhang A; Zhang C; Zheng Y; Jiang T; Pu P; Jiang C; Kang C
Oncol Rep; 2012 Mar; 27(3):854-60. PubMed ID: 22075712
[TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP‑9.
Chen XJ; Wu MY; Li DH; You J
Mol Med Rep; 2016 Sep; 14(3):2352-8. PubMed ID: 27430517
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ROCK2 through nanocomplex sensitizes the cytotoxic effect of temozolomide in U251 glioma cells.
Wen X; Huang A; Liu Z; Liu Y; Hu J; Liu J; Shuai X
PLoS One; 2014; 9(3):e92050. PubMed ID: 24642531
[TBL] [Abstract][Full Text] [Related]
15. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
[TBL] [Abstract][Full Text] [Related]
16. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
Han J; Chen Q
Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
[TBL] [Abstract][Full Text] [Related]
17. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
18. Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ.
Xu X; Wang Z; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Int J Oncol; 2018 Jul; 53(1):189-202. PubMed ID: 29749469
[TBL] [Abstract][Full Text] [Related]
19. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
Yang C; He L; Chen G; Ning Z; Xia Z
Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
[TBL] [Abstract][Full Text] [Related]
20. [Effect of osteopontin silencing by lentivirus-mediated delivery of siRNA on glioma cell invasion and apoptosis].
Yan W; Qian CF; Shi L; Qian J; Fu Z; Liu N; Lu AL; You YP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):525-8. PubMed ID: 19806573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
